HomeNewsIndiaCOVID-19 impact | CICSE announces up to 25% reduction in syllabus for 2021 board exams

COVID-19 impact | CICSE announces up to 25% reduction in syllabus for 2021 board exams

The Central Board of Secondary Education (CBSE) is also in the process of reducing the syllabus and has sought suggestions from various stakeholders. However, the final syllabus has not been notified yet.

July 03, 2020 / 23:26 IST
Story continues below Advertisement
Representative image
Representative image

Taking into account the learning disruption due to closure of schools during the COVID-19-induced lockdown, the Council for the Indian School Certificate Examinations (CISCE) on July 3 announced a reduction of up to 25 percent in syllabus for classes 10 and 12 board exams in 2021.

"...Schools across the country have been shut for the past three months due to the lockdown. While a number of CISCE-affiliated schools have tried to adapt to this changed scenario and have tried to keep alive the teaching learning process through online classes, there has been a significant shortening of the academic year and loss of the instructional hours," CICSE Chief Executive and Secretary Gerry Arathoon said.

Story continues below Advertisement

"To make up for the loss in instructional hours during the current session, the CISCE has worked with its subject experts, to reduce the syllabus for all major subjects at the ICSE (Class 10) and ISC (Class 12) levels. Syllabus reduction has been done, keeping in mind the linear progression across classes while ensuring that the core concepts related to the subject are retained," he added.

Arathoon said at present the syllabi has been reduced by up to 25 percent, but that is subject to further review of the prevailing conditions and the council may have to reduce it further in case the prevailing conditions don't turn conducive.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show